White Powder Pharmaceutical Material Methylprednisolone Anti Estrogen Steroids For Rheumatoid Arthritis CAS 83-43-2

Basic Information
Place of Origin: CHINA
Brand Name: TINGYI
Certification: GMP , ISO 9001:2008
Model Number: 83-43-2
Minimum Order Quantity: Negotiation
Price: Contact Us
Packaging Details: Stealth And Discreet Packaging
Delivery Time: Within 7 Work Days
Payment Terms: Bank Transfer - Bitcoin - Western Union - MoneyGram
Supply Ability: 100 KG/Month
Product Name: Methylprednisolone CAS: 83-43-2
Appearance: White Powder Shipping Method: EMS, HKEMS, FEDEX, DHL, UPS, Aramex, ETC
MF: C22H30O5 MW: 374.47
High Light:

pharmaceutical active ingredients


pharmaceutical anabolic steroids


White Powder Pharmaceutical Material Methylprednisolone Anti Estrogen Steroids For Rheumatoid Arthritis CAS 83-43-2




White Powder Pharmaceutical Material Methylprednisolone Anti Estrogen Steroids For Rheumatoid Arthritis CAS 83-43-2 0





Synonyms:(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione;11,17,21-trihydroxy-6-methyl-1,4-pregnadiene-3,20-dione ;11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione;11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione;1-dehydro-6alpha-methylhydrocortisone ;20-dione,11,17,21-trihydroxy-6-methyl-,(6alpha,11beta)-pregna-4-diene-3 ;20-dione,11-beta,17,21-trihydroxy-6-alpha-methyl-pregna-4-diene-3 ;20-dione,11beta,17,21-trihydroxy-6alpha-methyl-pregna-4-diene-3




Melting point:228-237°C (dec.)

alpha D20 +83° (dioxane)

refractive index 82 ° (C=1, Dioxane)

storage temp. 0-6°C

solubility chloroform/methanol (9:1): 50 mg/mL, clear, faintly yellow

Merck 6111





1. Anti-inflammatory treatment:

(rheumatic disease: as a short-term adjunct) (to help patients pass through acute or critical periods):

Posttraumatic osteoarthritis; synovitis caused by osteoarthritis; rheumatoid arthritis, juvenile rheumatoid arthritis (individual patients may need low dose maintenance treatment); acute or subacute bursitis; ankle arthritis; acute nonspecific tendon sheath inflammation; acute gouty arthritis; psoriatic arthritis; ankylosing spondylitis.

Collagen disorder (immune complex disease): critical illness or maintenance therapy for the following diseases:

Systemic lupus erythematosus (lupus nephritis); acute rheumatic myocarditis; systemic dermatomyositis (PM); polyarteritis nodosa; Goodpasture syndrome (Good pasture 's Syndrome). Skin disease: pemphigus; severe erythema multiforme (Stevens-Johnson syndrome); exfoliative dermatitis; bullous dermatitis herpetiformis; severe seborrheic dermatitis; severe psoriasis; mycosis fungoides; urticaria.

Allergy status: used to control the following to conventional treatment to deal with the serious damage caused by function or allergic diseases; bronchial asthma; contact dermatitis; atopic dermatitis; serum sickness; seasonal or perennial allergic rhinitis; allergic reaction; urticarial transfusion reaction; edema of acute non infective throat (epinephrine is the drug of choice).

- eye disease: severe acute and chronic ocular allergy and inflammation, such as herpes zoster; iritis, iridocyclitis; chorioretinitis; diffusion type real uveitis and choroiditis; optic neuritis; sympathetic ophthalmia.

Gastrointestinal disease: a critical period for patients to survive the following diseases; ulcerative colitis (systemic therapy); localized enterocolitis (systemic therapy). Respiratory disease: pulmonary sarcoidosis; beryllium poisoning;

Combined with appropriate anti tuberculosis chemotherapy for fulminant or diffuse tuberculosis;

Other methods cannot control Loeffler's syndrome (Loffler s Syndrome); aspiration pneumonia.

Edema: diuretic and urinary proteinuria for spontaneous or lupus nephrotic syndrome without uremia.

2. Immunosuppressive therapy: organ transplantation.
3. The treatment of blood diseases and tumors:

- blood diseases: acquired (autoimmune hemolytic anemia); adult idiopathic thrombocytopenic purpura (only intravenous injection, intramuscular injection of taboo); adult secondary thrombocytopenia; erythroblastopenia (anemia); congenital (red blood cell) aplastic anemia.

Tumor: palliative care for the following diseases; adult leukemia and lymphoma; childhood acute leukemia

4. Treatment shock:

Adrenal cortical insufficiency induced by shock, or because of adrenal cortical insufficiency and the shock had no response to conventional therapy (hydrocortisone for commonly used drugs; if you do not want to have the mineralocorticoid activity, using methylprednisolone).

Hemorrhagic, traumatic, and surgical shock without response to conventional therapy. Although there is no perfect (double-blind) clinical research, but animal experiment data show possible methylprednisolone to conventional therapy (e.g., rehydration) invalid effective shock. See also section of "infectious shock" in "precautions".

5. Other:

Nervous system:

Brain edema caused by primary or metastatic tumor, and (or) surgery and radiotherapy; acute severe stage of multiple sclerosis; acute spinal cord injury. Treatment should begin within 8 hours after trauma.

- combined with appropriate antituberculous therapy for tuberculous meningitis with subarachnoid obstruction or occlusion.

- involving nerve or myocardial trichinelliasis.

- prevention of nausea and vomiting caused by cancer chemotherapy.

6. Endocrine disorders:

Primary or secondary adrenal insufficiency;

Acute adrenocortical insufficiency;

(the above disease hydrocortisone or hydrocortisone as the drug of choice, if necessary, can be combined with synthetic glucocorticoid and mineralocorticoid.)

Patients who are known to have or may have adrenal insufficiency are administered before surgery and with severe trauma or disease.

Congenital adrenal hyperplasia; non suppurative thyroiditis; cancer induced hypercalcemia.



Hot Selling Products
Testosterone CAS: 58-22-0
Testosterone enanthate CAS: 315-37-7
Testosterone cypionate CAS: CAS: 58-20-8
Testosterone propionate CAS: 57-85-2
Testosterone phenylpropionate CAS: 1255-49-8
Testosterone isocaproate CAS: 15262-86-9
Testosterone decanoate CAS: 5721-91-5
Testosterone undecanoate CAS: 5949-44-0
Methyltestosterone (17-Alpha-Methyl-Testosterone) CAS: 65-04-3
Turinabol (4-Chlorotestosterone Acetate ,Clostebol Acetate) CAS: 855-19-6
oral turinabol (4-Chlorodehydromethyltestosterone) CAS: 2446-23-3
Oxymetholone (Anadrol) CAS: 434-07-1
Oxandrolone (Anavar) CAS: 53-39-4
Stanozolol (Winstroll) CAS: 10418-03-8
Stanolone CAS: 521-18-6
Mestanolone CAS:521-11-9
Methandrostenolone (Dianabol, methandienone) CAS:72-63-9
Nandrolone CAS:434-22-0
Nandrolone Decanoate CAS:360-70-3
Nandrolone Cypionate CAS:601-63-8
Nandrolone Phenypropionate CAS:62-90-8
Normethisterone CAS:514-61-4
Trenbolone CAS:10161-33-8
Trenbolone Acetate CAS:10161-34-9
Tibolone CAS:5630-53-5
Trestolone CAS:3764-87-2
Metribolone (Methyltrienolone) CAS:965-93-5
Tamoxifen Citrate (Nolvadex) CAS:54965-24-1
Clomiphene citrate CAS:50-41-9
Sildenafil citrate () CAS:171599-83-0
Tadalafil (Cialis) CAS:171596-29-5
Vardenafil CAS:224785-90-4
Boldenone CAS:846-48-0
Boldenone Acetate CAS:846-46-0
Boldenone Undecylenate CAS:13103-34-9

Contact Details
Sales Manager

WhatsApp : +8613657291547